DaVita Inc.
Business Model Analysis
How DaVita Makes Money
Annual Revenue: $13.6B
DaVita generates revenue primarily through Kidney care and dialysis services, with roughly $13.6B in annual revenue.
Core Growth Engine: DaVita's strategy is to grow earnings faster than revenue. It raises revenue per treatment, controls patient care costs, and buys back shares with free cash flow. It also expands international clinics (595 centers in 14 ...
Revenue Model & Pricing
DaVita is paid per dialysis treatment. Most patients receive in-center hemodialysis about three times a week, while others dialyze at home with DaVita training and support. Medicare's bundled ESRD payment covers the majority of patients, but commercial insurers pay substantially more per treatment, so payer mix is the key profit driver. In Q2 2026 U.S. revenue per treatment was $415.87 against patient care costs of $277.40. Many clinics are joint ventures with nephrology practices, and the Integrated Kidney Care (IKC) unit takes risk-based contracts, including the CMS Kidney Care Choices model, where DaVita shares in savings when total cost of care falls.
Core Revenue Streams
U.S. Dialysis and Related Lab Services
About 86%Revenue from U.S. outpatient dialysis treatments, related laboratory services, and payer reimbursement.
Other Ancillary Services and Strategic Initiatives
About 8%Includes integrated kidney care, value-based care arrangements, and other U.S. kidney-care initiatives.
International Dialysis
About 6%Dialysis services outside the United States across DaVita's international clinic network.
Growth Strategy
DaVita's strategy is to grow earnings faster than revenue. It raises revenue per treatment, controls patient care costs, and buys back shares with free cash flow. It also expands international clinics (595 centers in 14 countries by mid-2026), grows home dialysis, and scales Integrated Kidney Care risk contracts that pay for slowing disease progression and reducing hospitalizations. Through Mozarc Medical, its kidney-technology joint venture with Medtronic, it invests in new dialysis devices.
How DaVita Makes Money: FAQ
How does DaVita Inc. generate commercial revenue from kidney dialysis operations?
DaVita earns most revenue from per-treatment payments for outpatient, home, and hospital dialysis and related lab services. Medicare's bundled ESRD rate covers the medications given during dialysis. Additional revenue comes from Integrated Kidney Care risk contracts and international clinics.
What percentage of DaVita's dialysis treatments are paid by government programs versus commercial payers?
Government programs, mainly Medicare, Medicare Advantage, and Medicaid, cover roughly 90% of DaVita's U.S. dialysis patients. Commercial insurers cover about 10%.
How do commercial private insurance reimbursements subsidize government dialysis shortfalls?
Medicare's bundled rate is close to DaVita's cost per treatment, while commercial insurers pay much higher negotiated rates. A small commercial patient base therefore drives a disproportionate share of profit.
What is the Medicare End-Stage Renal Disease (ESRD) Prospective Payment System (PPS)?
Under federal US law, any American diagnosed with permanent kidney failure (ESRD) is automatically eligible for Medicare coverage regardless of age. Medicare reimburses dialysis providers under a bundled PPS prospective payment rate per treatment (set annually by CMS), adjusted for patient acuity and quality performance.
What is the DaVita Clinical Research (DCR) division?
DaVita Clinical Research supports clinical trials and real-world evidence studies in kidney disease with pharmaceutical and device companies.
How does DaVita partner with independent nephrologists through joint-venture clinics?
DaVita operates hundreds of its dialysis clinics as joint ventures with local nephrology physician practices. By sharing equity ownership and clinical governance, DaVita aligns clinical quality incentives with practicing kidney doctors while securing local patient referrals.
What is DaVita's hospital inpatient acute dialysis service model?
DaVita contracts with hospitals to provide inpatient and acute dialysis, supplying equipment and trained dialysis staff for patients with acute kidney injury or kidney failure.
How does DaVita expand its international kidney care footprint?
DaVita grows internationally through acquisitions and new clinics. It had 595 outpatient centers in 14 countries outside the U.S. at June 30, 2026.
How does DaVita make money?
DaVita operates a highly concentrated model. They own thousands of outpatient dialysis clinics. Because Medicare pays incredibly low rates for dialysis, DaVita makes nearly 100% of its net profit by heavily overcharging the small percentage of patients who have private commercial insurance.
Related Monetization Mechanics
Compare revenue streams, unit economics, and business models
Unitedhealth
Cvs Health
Hca Healthcare
Tenet Healthcare
Elevance Health
Berkshire Hathaway
Explore DaVita
Core profile pages, founders and related research hubs for this company.